bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2017: D N O S A J J M A M F J
2016: D

  Health Highlights: Jan. 31, 2017

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

George H.W. Bush Leaves Hospital

Former U.S. President George H.W. Bush left Houston Methodist Hospital Monday after spending more than two weeks there being treated for pneumonia.

Bush, 92, arrived at the hospital on Jan. 14 with breathing problems and had a blockage removed from his lung, NBC News reported.

He has a form of Parkinson's disease and has experienced other respiratory issues in recent years.

A few days after the former president arrived at the hospital, his 91-year-old wife Barbara Bush was also hospitalized for bronchitis. She was discharged a week ago, NBC News reported.

-----

Insulin Makers Conspired to Raise Prices: Lawsuit

Three makers of insulin conspired to boost the prices of the lifesaving diabetes drug, according to a lawsuit filed Monday in federal court in Massachusetts.

A recent study in the Journal of the American Medical Association said the price of insulin nearly tripled between 2002 and 2013, and three manufacturers -- Sanofi, Novo Nordisk and Eil Lilly -- have raised the list prices of their insulin in near unison, The New York Times reported.

The price increases have triggered anger among patient groups and doctors, who say the rising cost of insulin appears to have little to do with higher production costs.

"People who have to pay out of pocket for insulin are paying enormous prices, when they shouldn't be," Steve Berman, a lawyer for the patients, told The Times.

The lawsuits alleges that the three companies increased the list prices on their insulin in order to win favor with pharmacy benefit managers, who team with drug makers and health insurers to determine how a drug will be covered on a list of approved drugs.

While benefit managers are complicit, the lawsuit targets the drug makers because "they are playing the game, and they are the ones who publish the list price," Berman said.

Representatives for the three drug companies could not immediately be reached for comment, The Times reported.

The lawsuit includes several examples of diabetes patients who can't afford the up-to-$900 cost of their insulin and have resorted to using expired insulin or starving themselves to control their blood sugar.

Copyright © 2017 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=719186

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Association
Blood
Specialty Chemicals and Products
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Inicio img Sobre nosotros img Rincón de la prensa img Boletín HON img Mapa del sitio img Política ética img Contactos